ProjectImmunopeptidomics von kleinzelligem Lungenkarzinom
Basic data
Title:
Immunopeptidomics von kleinzelligem Lungenkarzinom
Duration:
01/07/2019 to 30/06/2023
Abstract / short description:
In Teilprojekt C03 des SFB 1399 ( „Mechanismen der Medikamenten-Empfindlichkeit und Resistenz beim kleinzelligen Bronchialkarzinom“ ) sollen das MHC-Klasse-I- und -Klasse-II-Ligandom von SCLC entschlüsselt, immunogene neo- und nicht-mutierte T Zell-Antigene von SCLC identifiziert und tumorspezifische T Zellen in SCLC-Patienten charakterisiert werden.
Involved staff
Managers
Faculty of Medicine
University of Tübingen
University of Tübingen
Institut for Immunology
Non-clinical institutes, Faculty of Medicine
Non-clinical institutes, Faculty of Medicine
Contact persons
Cluster of Excellence: Image-Guided and Functionally Instructed Tumor Therapies (iFIT)
Centers or interfaculty scientific institutions
Centers or interfaculty scientific institutions
Institut for Immunology
Non-clinical institutes, Faculty of Medicine
Non-clinical institutes, Faculty of Medicine
Local organizational units
Immunology †
Interfaculty Institute for Cell Biology (IFIZ) †
Interfaculty Institutes
Interfaculty Institutes
Funders
Bonn, Nordrhein-Westfalen, Germany